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Background: Previous studies have reported that the signal attenuation of diffusion-weighted magnetic resonance
imaging (DWI) for normal breast tissue and tumor were well fitted by a monoexponential and a biexponential function,
respectively. The aim of this study was to investigate the optimal b-value to detect breast tumors from DWI signal attenuations.
Methods: Sixty-four subjects with breast cancer underwent DWI using six b-values up to 3500 s/mm2. The signal
attenuations of normal breast and tumor were fitted by mono- and biexponential functions, respectively. The
maximum contrast b-values were estimated and compared in terms of frequency.
Results: In almost all cases, the contrast increased with a b-value from 0 to approximately 1500 s/mm2. For b >
1500 s/mm2, the contrast decreased. The highest contrast b-value in the range of 0 to 2500 s/mm2 most
frequently was b = 1500 and the next most frequent was 1400 s/mm2. Comparing sensitivity and specificity
between b = 700 and b = 1400 s/mm2, b =1400 s/mm2 was slightly superior.
Conclusion: Based on these results, DWI with a b-value of approximately 1400-1500 s/mm2 is recommended for
optimizing breast tumor detectability.Background
MRI is the most sensitive imaging modality for the detec-
tion of breast cancer; however, the reported specificity is
variable [1]. Generally, breast MRI diagnosis emphasizes
tumor shape, margins, internal enhancement, and dy-
namic pattern using images acquired after a bolus injec-
tion of contrast media [2]. Furthermore, it had been
reported that adding information from diffusion-weighted
imaging (DWI) increases the specificity [3,4]. DWI can be
used to distinguish between tissues by detecting differ-
ences in the diffusion properties of their water mole-
cules. It is used to detect malignant tumors because the
diffusion of water molecules in a malignant tumor is re-
stricted and therefore the transit distances have shorter
than in normal parenchyma [5-10]. DWI is often used
in breast imaging, and many reports demonstrate its
clinical utility [3,4,11-23]. In a meta-analysis of DWI of breast* Correspondence: tamutaka417@gmail.com
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unless otherwise stated.tumors performed at 1.5 T, Tsushima et al. [23] reported a
sensitivity of 0.89 and specificity of 0.77, comparable to the re-
sults of the meta-analysis of contrast-enhanced breast MR im-
aging reported by Peters et al. [20] with a sensitivity of 0.90
and specificity of 0.72. Several studies have reported that
the apparent diffusion coefficient (ADC) is useful in dis-
criminating between malignant and benign breast tumors
[3,11-23], but the threshold value of ADC for such dis-
crimination can range from 1.1 to 1.6 × 10−3 mm2/s, and
it is affected by the maximum b-value [23]. These ADCs
were calculated by the following monoexponential equa-
tion using 2 or 3 b-values up to 1500 s/mm2,
Sb=S0 ¼ exp −bDð Þ ð1Þ
where S0 and Sb are the signals without and with diffu-
sion sensitizing gradients, respectively; b is the b-value,
and D is the ADC [24]. However, the application of
Equation (1) for measuring diffusion in vivo is problem-
atic. The actual signal attenuation of breast tumors is
non-monoexponential [25]; therefore, calculated ADCs
using different b-values are also different [23].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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b = 0–1000 s/mm2 with a 250 s/mm2 interval to perform
1.5-T MR imaging, Pereira et al. [26] reported that the
ADC calculated from b = 0 and 750 s/mm2 was slightly
better than other b-value combinations for distinguish-
ing malignant from benign. In a similar study using
3.0 T MRI, Bogner et al. [27] reported that the combin-
ation of b = 50 and 850 s/mm2 was slightly better, and
using b-values over 1000 s/mm2 could lead to overdiagno-
sis and was not appropriate. However, Ochi et al. [3] re-
ported that ADC values calculated from b = 1500 s/mm2
were useful to improve the diagnostic accuracy for malig-
nant tumors and benign lesions, especially for noninvasive
ductal carcinoma (NIDC) versus fibrocystic changes, ex-
cept in cases of ductal hyperplasia. These differing results
suggest that the optimum b-value for calculating the ADC
has not yet been agreed upon. Additionally, it is well
known that there is overlap between the ADCs of malig-
nant and benign neoplasms [23], and although ADCFigure 1 DWIs of a 39-year-old woman with invasive ductal carcinoma o
3500 (f) s/mm2 and 3D T1-weighted fast gradient-echo image at 70 second af
breast (h) and tumor (i) on the DWI. DWI signal attenuations of the normal brereflects cell density, it does not directly reflect the charac-
ter of the malignancy [11,19,28]. Proliferative tumors, both
benign and malignant, exhibit high signal in DWI [22].
Another aim of DWI is the detection of tumors in gen-
eral [18,22]. The optimum b-value for tumor detection
has also not yet been agreed upon. There have been many
recent studies of DWI using b-values > 1000 s/mm2
[3,12,21,25-29]. Higher b-values are able to apply weight-
ings to more restricted diffusion but also cause de-
creased signal-to-noise ratio (SNR). Thus, excessively
higher b-values do not improved tumor detection. In
our previous study, we analyzed the DWI signal attenu-
ation of normal mammary gland and breast tumors
using multiple b-values up to 3500 s/mm2 and demon-
strated that normal breasts and malignant tumors were
well fitted by a monoexponential and biexponential
function, respectively [25]. The aim of the current study is
to investigate the optimum b-value to detect breast tu-
mors, surveying multiple b-value DWI signal attenuations.f the left breast. b-value = 0 (a); 700 (b); 1400 (c); 2100 (d); 2800 (e); and
ter contrast administration (g). Illustrated positions of the ROIs of normal
ast and tumor (j) and derived contrast with function of b-value (k).
Table 1 Scan parameters of breast MRI study
Technique TR/TE/FA Matrix FOV Thickness/Gap NEX SENSE Fat Sat. Scan time
DWI 2D-SE-EPI 5600/99/90 128 × 114(256R) 280 mm 4/0.4 mm 3 Factor 2.0 SPAIR 4 m 40 s
T2WI 2D-FSE 6200/80/90 256 × 198(256R) 280 mm 4/0.4 mm 2 Factor 2.0 SPAR 1 m 58 s
T1WI 2D-GRE 268/5.5/80 256 × 198(256R) 280 mm 4/0.4 mm 1 Factor2.0 Non 1 m 27 s
Dynamic 3D-Fast-GRE 7.7/3.8/12 352 × 334(512R) 280 mm 1.2/-0.6 mm 1 Factor2.0 SPAIR 70 s × 3
High-Resolution 3D-Fast-GRE 8.6/4.3/12 512 × 496(512R) 280 mm 1.21-0.6 mm 1 Factor2.0 SPAIR 3 mls
Figure 2 Diffusion attenuation in 4% CuSo4-doped saline at 22°C
indicating a linear signal decay until it reached background level.
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Subjects
This study was approved by our center’s Institutional
Review Board (Hiroshima Atomic Bomb Casualty IRB,
Trial registry number, 5) and all patients gave their in-
formed consent. The subjects included 62 females with a
total of 64 breast cancers (mean age = 56.0 years, age
range = 33–81 years, mean tumor size = 2.17 ± 1.48 cm)
and 38 normal controls (mean age 55.4 years, age range =
35–78 years). All subjects underwent breast magnetic res-
onance imaging (MRI) including DWI with multiple b-
values. All tumors were excised and the final diagnosis
established on the basis of histopathological examination.
According to the World Health Organization classifica-
tion, the 64 breast tumors were comprised of noninvasive
ductal carcinoma (NIDC; n = 9), invasive carcinoma (IDC;
n = 49), tubulo-lobular carcinoma (n = 3), mucinous car-
cinoma (n = 2), and medullary carcinoma (n = 1).
MR imaging
All MR imaging was performed using a 1.5 T supercon-
ducting magnet (Gyroscan Achieva R.2.6; Philips Medical
Systems, Best, The Netherlands) with a 7-channel SENSE
breast coil. In the prone position, patients underwent
diffusion-weighted axial imaging using the spin-echo type
single-shot echo planar imaging (EPI) technique. We used
the tetrahedral diffusion gradient technique [30] to sup-
press prolongation of the echo time (TE) and obtained
four image series, from which the isotropic diffusion gra-
dient strength images were generated. The six diffusion b-
values ranged from 0 to a maximum of 3500 s/mm2 with
an interval of 700 s/mm2 (Figure 1a–f ). The diffusion gra-
dient duration (δ) was 37 ms with an interval (Δ) of
48.5 ms; both were fixed at every b-value, with only the
diffusion-sensitizing gradient strength (G) changed with
each change in the b-value. Thus, the diffusion duration
(Δ - δ/3) was constant at 36 ms. The other parameters
used for the DWI sequence are shown in Table 1. After
the DWI, bilateral axial examinations consisting of a fast
spin-echo T2-weighted sequence with fat suppression and
a T1-weighted gradient-echo sequence were performed.
For the dynamic contrast-enhanced examination, 3D T1-
weighted fast gradient-echo sequences were acquired be-
fore, 70 seconds (early phase) (Figure 1g), and 5 minutes
(delayed phase) after the bolus injection of gadoliniumcontrast media (dose: 0.2 ml/kg, rate: 2 ml/s). During the
dynamic examination (3 minutes after the injection), an
additional high-resolution 3D T1-weighted fast gradient-
echo sequence was acquired (Table 1).
Prior to the clinical study, we determined DWI signal at-
tenuation of 4% CuSo4-doped saline to confirm the linear-
ity of the diffusion gradient with each b-values. The scan
parameters were identical to those of the clinical study
without b-values. The number of diffusion b-values was
changed to sixteen from six with an interval of 233 s/mm2,
thereby, scan time was extended to 35 min 20 s.
Regions of interest
We displayed and analyzed DWI images using “ImageJ”
(National Institutes of Health, Bethesda, Maryland, USA;
http://rsbweb.nih.gov/ij/), a freely available DICOM viewer.
We placed a region of interest (ROI) in a target tumor
and in the contralateral normal breast on DWI. In tu-
mors, we confirmed the orientation using the DWI of
b = 700 and 1400 by comparing early phase images of the dy-
namic study. ROIs were smaller than the mass size and ex-
cluded areas of normal-appearing tissue (mean size = 112 ±
Figure 3 Signal attenuation of all cases of normal breasts (a), NIDC (b), IDC (c) and special type tumors (d).
Table 2 Derived parameters from the biexponential
fitting in malignant tumors
n ffast Dfast Dslow
NIDC 9 0.717 ± 0.114 2.07 ± 0.319 0.179 ± 0.10
IDC 49 0.624 ± 0.125 2.08 ± 0.48 0.192 ± 0.09
Special type 6 0.673 ± 0.172 2.05 ± 0.32 0.203 ± 0.10
ffast: fast component fraction, Dfast: fast component ADC (×10
−3 mm2/s),
Dslow: slow component ADC (×10
−3 mm2/s), NIDC: Non-invasive ductal
carcinoma, IDC: Invasive ductal carcinoma.
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nipple level’s mammary grand as large as possible ex-
cluding the area of fat (mean size = 503.4 ± 417.2 pixels)
(Figure 1h). We plotted the DWI signal using in-house
software developed in a commercial analysis package
(Matlab v.7.8, MathWorks Inc., Natick, MA, USA) and
fitted the data using the Levenberg-Marquardt algo-
rithm [31] for malignant tumors as follows:
Sb=S0 ¼ f fast exp −bDfastð Þ þ 1−f fastð Þ exp −bDslowð Þ þ BG
ð2Þ
where f is the fraction of each component, the subscripts
indicates the fast and slow components and BG is back-
ground [32], and used equation (1) for normal mammary
glands.
Tumor and normal breast contrast
Using the parameters calculated from signal fitting, we
reproduced the signal decay of tumor and normal breast
tissue and calculated the contrast between them from b = 0to 3000 s/mm2 with an interval of 100 s/mm2 from the fol-
lowing equation:
Contrast ¼ Signal tumorð Þ−Signal normal breastð Þf g=
Signal tumorð Þ þ Signal normal breastð Þf g
ð3Þ
In each case, we investigated the maximum contrast
b-value and counted the frequency of maximum contrast
b-values in all cases.
Figure 4 Contrast curves between tumor and normal breast for
all cases.
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We evaluated the sensitivity and specificity using b = 700
and 1400 s/mm2 of DWI by three observers (TT, MS,
and NK with 11, 10, and 9 years of expertise in breast
MRI diagnosis, respectively). The subjects were a total
of 100 cases including the 62 patients (64 breast can-
cers) and the additional 38 normal cases. A total of 200
images (400 breasts) were randomly sorted and evalu-
ated the ability of tumor detection and localization.
The results were compared using the chi-square test
(95% confidence interval); a p value < 0.05 was consid-
ered significant.Figure 5 Frequency of maximum contrast b-value between tumor anResults
Tumor and normal breast contrast
The signal decay as a function of b factor for the 4%
CuSo4-doped saline (22°C), shown in Figure 2, was
found to be monoexponential, as expected. The diffusion
coefficient obtained from the fit was 2.10 × 10−3 mm2/s,
in close agreement with the value obtained by Niendorf
et al. [33] of 2.04 × 10−3 mm2/s.
All of the normal mammary gland and tumor DWI sig-
nal attenuations are shown in Figure 3. All normal breast
signal decays were fitted by the monoexponential equation
(1) and tumors were fitted by the biexponential equation
(2). The mean ADC of normal breast tissue was 2.48 ±
0.33 × 10−3 mm2/s. In malignant tumor, derived parame-
ters from the biexponential fitting are displayed in Table 2.
Figure 4 shows the normal breast-to-malignant tumor
contrast for all case. In almost every case, the contrast in-
creased with the b-value from b = 0 to around 1500 s/mm2;
for b > 1500 s/mm2, the contrast decreased. Figure 5
shows the frequency of the highest contrast b-values.
Almost every case had the highest contrast in the range
of b = 0–2500 s/mm2 and the most frequent were b =
1400–1500 s/mm2.
Sensitivity and specificity of DWI
Table 3 gives the sensitivity and specificity of DWI per-
formed with b = 700 and 1400 s/mm2. There is no differ-
ence between b = 700 and 1400 s/mm2 in terms of
sensitivity and specificity for observer A; in the other
two observers, both the sensitivity and specificity of b =
1400 s/mm2 were slightly better than for b = 700 s/mm2.d normal breast.
Table 3 The sensitivity and specificity of DWI using
b = 700 and 1400 s/mm2
Sensitivity Specificity
Observer b = 700 b = 1400 b = 700 b = 1400
A 0.871 0.871 0.853 0.853
B 0.871 0.903 0.794 0.912
C 0.871 0.903 0.941 0.971
Mean 0.871 0.892 0.863 0.912
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mm2 was 0.871 and 0.892, respectively, and the mean spe-
cificity was 0.863 and 0.912, respectively. For both criteria,
b = 1400 s/mm2 was slightly better than b = 700 s/mm2.
However, there were no significant differences in either
sensitivity or specificity between b = 700 and b = 1400
(p = 0.504 for sensitivity, p = 0.197 for specificity).
Discussion
In this study, we assessed the DWI signal attenuation of
normal breasts and tumors up to b =3500 s/mm2 usingFigure 6 DWIs of a 59-year-old woman with mucinous carcinoma of t
and 3500 (f) s/mm2 and 3D T1-weighted fast gradient-echo image at 70 seco
breast (h) and tumor (i) on the DWI. DWI signal attenuations of the normal bmultiple b-value DWI data, and calculated the maximum
contrast between normal breast and tumor. The frequen-
cies of the maximum contrast b-values between malignant
tumor and normal breast were widely distributed within
the range of b = 0 to b = 2500 s/mm2; the most frequent
b-value was b = 1500 s/mm2 (16.9%, 11/65) and the next
was b = 1400 s/mm2 (12.3%, 8/65) (Figure 5).
The tumor-to-normal breast contrast of almost all
cases increased with a b-value from b = 0 to approxi-
mately 1500 s/mm2, and decreased with b > 1500 s/mm2
(Figure 4). Increasing the b-value caused the DWI signal
to decrease and in almost all cases of normal breast, the
signal declined until it reached the background noise
level at around b = 1000–1500 s/mm2. In addition, for
b ≥ 1500 s/mm2, normal breast signals were constant
as the background and tumor signals were residual
(Figure 3). Consequently, the maximum contrast b-values
were of high frequency at approximately b = 1500 s/mm2.
There were two cases in which the highest contrast
b-value was estimated to be 0 s/mm2. These two cases
were a NIDC and a mucinous carcinoma and both werehe left breast. b-value = 0 (a); 700 (b); 1400 (c); 2100 (d); 2800 (e);
nd after contrast administration (g). Illustrated positions of ROIs of normal
reast and tumor (j) and derived contrast with function of b-value (k).
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displayed high intensity in DWI b = 700 and b = 1400 s/mm2
(Figures 6 and 7).
Subsequently, we examined the sensitivity and speci-
ficity of DWI at b = 700 and 1400 s/mm2, which was
where the maximum contrast was seen in only two
cases and where the higher frequency was observed, re-
spectively. This was done to confirm whether the tumor
detectability could be evaluated or not by using the opti-
mal b-value (Table 3). As a result, the mean sensitivity and
specificity of the three observers of the b = 1400 s/mm2
data were slightly superior to those for b = 700 s/mm2.
By comparing the sensitivity and specificity, unfortu-
nately, there was no statistically significant difference
(p = 0.504 for sensitivity, p = 0.197 for specificity). How-
ever, for DWI, the residual signal of normal breast
tissue suppresses the conspicuity of tumor. The DWI at
b = 1400 s/mm2, without residual signal from normal
tissue, is more likely to detect tumor.
In a similar study using 6 b-values up to b = 3000 s/mm2
and a 3.0 T MRI, Takanaga et al. [29] reported that the
maximum contrast b-value between tumor and normal
breast tissue was 1500 s/mm2 and they concluded that theFigure 7 DWIs of a 39-year-old woman with NIDC of the right breast. b
and 3D T1-weighted fast gradient-echo image at 70 second after contrast adm
breast (i) on the DWI. DWI signal attenuations of the normal breast and tumodecline of b-values for normal-breast-to-background level
is higher than 1.5 T, because the SNR of 3.0 T MRI is
higher than that of 1.5 T. As a result, the highest contrast
b-value for 3.0 T might be higher than that of 1.5 T. How-
ever, the b-value using 1.5 T MRI was the same in our
study. Matsuoka et al. [34] reported that there was no
significant difference for breast tumor ADCs between
1.5 T and 3.0 T. We consider that the DWI signal at-
tenuation does not depend on the magnetic field
strength; consequently, there was no difference between
the maximum contrast b-values for 1.5 and 3.0 T.
There are some limitations in the present study. First,
we reproduced the DWI signal decay using only 6 b-value
images because of limitations in examination time, and
less data may cause incorrect signal decay reproduction.
As the decay of normal breast declines to the background
noise level until the lower b-value, there were only two or
three data points generated during decay. Thus, there is a
possibility that accurate signal attenuation cannot be
reproduced. Furthermore, the shape of decay is affected
by the ROI’s position and shape. Because of the hetero-
geneity within the tumor, DWI signal attenuation is differ-
ent depending on the ROI’s position and shape. In this-value = 0 (a); 700 (b); 1400 (c); 2100 (d); 2800 (e); and 3500 (f) s/mm2
inistration (g). Illustrated positions of ROIs of tumor (h) and normal
r (i) and derived contrast with function of b-value (j).
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tumor, thus the contrast between tumor and normal tissue
might be underestimated and the estimated maximum
contrast b-value may differ from actual values. Even with
the presence of the abovementioned uncertainties, we
speculate that maximum contrast b-values exist around
b = 1500 s/mm2 with high frequency.
As a result of this study, the optimum b-value to de-
tect breast tumors depends on the case, and so we con-
sider it to be impossible to determine a single optimal b-
value. Generally, the b-value is selected to be less than
1000 s/mm2 in breast DWI, although we recommend
the use of approximately b-1500 s/mm2 to improve the
diagnostic performance. However, we do not recom-
mend the use of high b-values greater than 1000 s/mm2
only, because there are some reports that the accuracy
of ADC to distinguish malignant from benign tissue is
greatest when using values of b < 1000 s/mm2 [26,27].
Consequently, we recommend using a combination of
b = 750–850 s/mm2 for calculating ADC and b = 1400–
1500 s/mm2 for detecting tumors. Using multiple
b-value DWI causes prolongation of the scan time and
so it may not be suitable to perform these steps in the
limited time available. Additionally, it is impossible to
set multiple b-values with some vendors’ machines, and
selecting different b-values can cause more change in
the TE. Higher b-values cause decreased SNR because
of diphase due to water molecule diffusion; prolonga-
tion of TE will be further conducive to this. Therefore,
tumor detection might become difficult under such
conditions. Thus, we hope that advancement of tech-
nology for employing multiple b-values will enable their
use in all vendors’ machines in a shorter TE with higher
SNR.
Conclusion
We evaluated the malignant tumor/normal mammary
gland contrast of 1.5 T breast DWI using six b-values up to
3500 s/mm2 and investigated the optimal b-value to detect
breast cancer. As a result, the maximum contrast b-value
was distributed around b = 0 to 2500 s/mm2, and b = 1400
and 1500 s/mm2 were the most frequent. Comparing sensi-
tivity and specificity between b = 700 and 1400 s/mm2,
b = 1400 s/mm2 was slightly superior to b = 700 s/mm2.
From these results, DWI with a b-value of 1400–
1500 s/mm2 is recommended for improving breast
tumor detectability. Given that there are some reports that
b = 750–850 is suitable for distinguishing malignant from
benign tissue using ADC, we recommend performing
multiple b-value DWI combinations (b = 750–850 s/mm2
and 1400–1500 s/mm2) for breast DWI.
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